Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles

Pharmacological Reviews

Volumn 64, Issue 3, 2012, Pages 505-519

  Morachis, José M ^a   Mahmoud, Enas A ^a   Almutairi, Adah ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASIALOGLYCOPROTEIN RECEPTOR; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FIRTECAN; FOLATE BINDING PROTEIN; FOLATE RECEPTOR; GALACTOSAMINE; GELATINASE A; GELATINASE B; GLYCOPROTEIN; HEMOGLOBIN; MACROGOL; N (2 HYDROXYPROPYL)METHACRYLAMIDE; NANOPARTICLE; POLYMER; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; STREPTAVIDIN; TRANSFERRIN RECEPTOR; VACCINE; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANISOTROPY; ARTICLE; BLOOD BRAIN BARRIER; BODY TEMPERATURE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; COMPARATIVE STUDY; CROSS LINKING; DENDRITIC CELL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; ERYTHROCYTE; HELA CELL; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIGHT; MACROPHAGE; MELANOMA CELL; MESENCHYMAL STEM CELL; METASTASIS; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PHAGOCYTOSIS; PLASMA HALF LIFE; PRIORITY JOURNAL; TEMPERATURE; TUMOR MICROENVIRONMENT; ULTRAVIOLET RADIATION;

EID: 84930484572     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.111.005363     Document Type: Article

References (119)

1. Acharya S, Dilnawaz F, and Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30: 5737-5750
2. Aktaş Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Riguera R, Sargon MF, et al. (2005) Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 Bioconjug Chem 16:1503-1511
3. Andresen TL, Thompson DH, and Kaasgaard T (2010) Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. Mol Membr Biol 27:353-363
4. Bae Y, Nishiyama N, and Kataoka K (2007) In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 18:1131-1139
5. Bandyopadhyay A, Fine RL, Demento S, Bockenstedt LK, and Fahmy TM (2011) The impact of nanoparticle ligand density on dendritic-cell targeted vaccines. Biomaterials 32:3094-3105
6. Bédard MF, De Geest BG, Skirtach AG, Möhwald H, and Sukhorukov GB (2010) Polymeric microcapsules with light responsive properties for encapsulation and release. Adv Colloid Interface Sci 158:2-14
7. Beningo KA and Wang YL (2002) Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci 115:849-856
8. Bicho A, Peça IN, Roque AC, and Cardoso MM (2010) Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8 Int J Pharm 399:80-86
9. Boomer JA, Inerowicz HD, Zhang ZY, Bergstrand N, Edwards K, Kim JM, and Thompson DH (2003) Acid-triggered release from sterically stabilized fusogenic liposomes via a hydrolytic DePEGylation strategy. Langmuir 19:6408-6415
10. Brasseur R and Divita G (2010) Happy birthday cell penetrating peptides: already 20 years. Biochim Biophys Acta 1798:2177-2181
11. Buse J and El-Aneed A (2010) Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. Nanomedicine 5:1237-1260
12. Chakravarthi SS, De S, Miller DW, and Robinson DH (2010) Comparison of antitumor efficacy of paclitaxel delivered in nano- and microparticles. Int J Pharm 383:37-44
13. Champion JA and Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103:4930-4934
14. Champion JA and Mitragotri S (2009) Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26:244-249
15. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH, and Simon RP (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18:4914-4928
16. Cheng H, Kastrup CJ, Ramanathan R, Siegwart DJ, Ma M, Bogatyrev SR, Xu Q, Whitehead KA, Langer R, and Anderson DG (2010) Nanoparticulate cellular patches for cell-mediated tumoritropic delivery. ACS Nano 4:625-631
17. Chithrani BD, Ghazani AA, and Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668
18. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ittyipe B, Bawendi MG, and Frangioni JV (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170
19. Chonn A, Cullis PR, and Devine DV (1991) The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. The Journal of Immunology 146:4234-4241
20. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, and Huang DM (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28:2959-2966
21. Cohen JA, Beaudette TT, Tseng WW, Bachelder EM, Mende I, Engleman EG, and Fréchet JM (2009) T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem 20:111-119
22. Cohen JL, Almutairi A, Cohen JA, Bernstein M, Brody SL, Schuster DP, and Fréchet JM (2008) Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. Bioconjug Chem 19:876-881
23. Convertine AJ, Diab Ç Prieve M, Paschal A, Hoffman AS, Johnson PH and Stayton PS (2010) pH-responsive polymeric micelle carriers for siRNA drugs. Biomacromolecules 11:2904-2911
24. Conway MA, Madrigal-Estebas L, McClean S, Brayden DJ, and Mills KH (2001) Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 19: 1940-1950
25. Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, and Figdor CG (2010) Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release 144: 118-126
26. Davis ME (2009) The first targeted delivery of siRNA in humans via a selfassembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6:659-668
27. De P, Gondi SR, and Sumerlin BS (2008) Folate-conjugated thermoresponsive block copolymers: highly efficient conjugation and solution self-assembly. Biomacromolecules 9:1064-1070
28. Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, and Ferrari M (2010) Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 141: 320-327
29. Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, and Jain RK (2000) Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer 82:1513-1518
30. Deshayes S, Morris MC, Divita G, and Heitz F (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62:1839-1849
31. Doshi N, Prabhakarpandian B, Rea-Ramsey A, Pant K, Sundaram S, and Mitragotri S (2010) Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J Control Release 146: 196-200
32. Doshi N, Zahr AS, Bhaskar S, Lahann J, and Mitragotri S (2009) Red blood cellmimicking synthetic biomaterial particles. Proc Natl Acad Sci USA 106:21495-21499
33. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, and McGrath JL (2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30:603-610
34. Eifler AC and Thaxton CS (2011) Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. Methods Mol Biol 726:325-338
35. Eldridge JH, Staas JK, Meulbroek JA, Tice TR, and Gilley RM (1991) Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 59:2978-2986
36. Fischer R, Fotin-Mleczek M, Hufnagel H, and Brock R (2005) Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides. Chembiochem 6:2126-2142
37. Fomina N, McFearin C, Sermsakdi M, Edigin O, and Almutairi A (2010) UV and near-IR triggered release from polymeric nanoparticles. J Am Chem Soc 132: 9540-9542
38. Frankel AD and Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193
39. Gao W, Chan JM, and Farokhzad OC (2010) pH-Responsive nanoparticles for drug delivery. Mol Pharm 7:1913-1920
40. Gao ZG, Lee DH, Kim DI, and Bae YH (2005) Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target 13:391-397
41. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, and Discher DE (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249-255
42. Goodwin AP, Mynar JL, Ma Y, Fleming GR, and Fréchet JM (2005) Synthetic micelle sensitive to IR light via a two-photon process. J Am Chem Soc 127:9952-9953
43. Gratton SE, Napier ME, Ropp PA, Tian S, and DeSimone JM (2008a) Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm Res 25:2845-2852
44. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, and DeSimone JM (2008b) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105:11613-11618
45. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, and Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603
46. Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, and Farokhzad OC (2008) Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA 105:2586-2591
47. Gutierro I, Hernández RM, Igartua M, Gascón AR, and Pedraz JL (2002) Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21:67-77
48. Haghgooie R, Toner M, and Doyle PS (2010) Squishy non-spherical hydrogel microparticles. Macromol Rapid Commun 31:128-134
49. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, and McDonald DM (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156:1363-1380
50. Hatakeyama H, Ito E, Akita H, Oishi M, Nagasaki Y, Futaki S, and Harashima H (2009) A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release 139:127-132
51. He C, Hu Y, Yin L, Tang C, and Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657-3666
52. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, and Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607-4612
53. Huang HC, Barua S, Sharma G, Dey SK, and Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155:344-357
54. Huang X, Teng X, Chen D, Tang F, and He J (2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31:438-448
55. Jain RK (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9:253-266
56. Jiang J, Tong X, Morris D, and Zhao Y (2006) Toward photocontrolled release using light-dissociable block copolymer micelles. Macromolecules 39:4633-4640
57. Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, and Kissel T (2001) Tetanus toroid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graftpoly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res 18:352-360
58. Katare YK, Muthukumaran T, and Panda AK (2005) Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharm 301:149-160
59. Keller M (2009) Nanomedicinal delivery approaches for therapeutic siRNA. Int J Pharm 379:210-211
60. Kumari A, Yadav SK, and Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1-18
61. Kwon YJ, James E, Shastri N, and Fréchet JM (2005) In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pHresponsive microparticles. Proc Natl Acad Sci USA 102:18264-18268
62. Lee ES, Gao Z, Kim D, Park K, Kwon IC, and Bae YH (2008) Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance. J Control Release 129:228-236
63. Lee ES, Na K, and Bae YH (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103:405-418
64. Lorenz MR, Holzapfel V, Musyanovych A, Nothelfer K, Walther P, Frank H, Landfester K, Schrezenmeier H, and Mailänder V (2006) Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27:2820-2828
65. Maham A, Tang Z, Wu H, Wang J, and Lin Y (2009) Protein-based nanomedicine platforms for drug delivery. Small 5:1706-1721
66. Mahmoud EA, Sankaranarayanan J, Morachis JM, Kim G, and Almutairi A (2011) Inflammation responsive logic gate nanoparticles for the delivery of proteins. Bioconjug Chem 22:1416-1421
67. Mainardes RM, Gremião MP, Brunetti IL, da Fonseca LM, and Khalil NM (2009) Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J Pharm Sci 98:257-267
68. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, and Bachmann MF (2008) Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 38:1404-1413
69. McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi MG, Boucher Y, Breakefield XO, and Jain RK (2006) Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res 66:2509-2513
70. Merkel TJ, Jones SW, Herlihy KP, Kersey FR, Shields AR, Napier M, Luft JC, Wu H, Zamboni WC, Wang AZ, et al. (2011) Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA 108:586-591
71. Nagamoto T, Hattori Y, Takayama K, and Maitani Y (2004) Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 21:671-674
72. Nakaoka R, Inoue Y, Tabata Y, and Ikada Y (1996) Size effect on the antibody production induced by biodegradable microspheres containing antigen. Vaccine 14:1251-1256
73. Napoli A, Valentini M, Tirelli N, Müller M, and Hubbell JA (2004) Oxidationresponsive polymeric vesicles. Nat Mater 3:183-189
74. Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, et al. (1996) Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 14:1523-1530
75. Norman ME, Williams P, and Illum L (1992) Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials 13:841-849
76. O'Hagan DT, Jeffery H, and Davis SS (1993) Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 11:965-969
77. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Gross LA, and Tsien RY (2009) In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) 1:382-393
78. Owens DE 3rd and Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93-102
79. Ozpolat B, Sood AK, and Lopez-Berestein G (2010) Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med 267:44-53
80. Peng CL, Tsai HM, Yang SJ, Luo TY, Lin CF, Lin WJ, and Shieh MJ (2011) Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release. Nanotechnology 22:265608
81. Petros RA and DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615-627
82. Photos PJ, Bacakova L, Discher B, Bates FS, and Discher DE (2003) Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Release 90:323-334
83. Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, Brown EB, Izumi Y, Campbell RB, Berk DA, et al. (2001) Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci USA 98:4628-4633
84. Poon Z, Lee JA, Huang S, Prevost RJ, and Hammond PT (2011) Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting. Nanomedicine 7:201-209
85. Popović Z, Liu W, Chauhan VP, Lee J, Wong C, Greytak AB, Insin N, Nocera DG, Fukumura D, Jain RK, et al. (2010) A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl 49:8649-8652
86. Prencipe G, Tabakman SM, Welsher K, Liu Z, Goodwin AP, Zhang L, Henry J, and Dai H (2009) PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 131:4783-4787
87. Rahimi M, Kilaru S, Sleiman GE, Saleh A, Rudkevich D, and Nguyen K (2008) Synthesis and characterization of thermo-sensitive nanoparticles for drug delivery applications. J Biomed Nanotechnol 4:482-490
88. Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, and Swartz MA (2006) In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 112:26-34
89. Rehor A, Hubbell JA, and Tirelli N (2005) Oxidation-sensitive polymeric nanoparticles. Langmuir 21:411-417
90. Romberg B, Hennink WE, and Storm G (2008) Sheddable coatings for longcirculating nanoparticles. Pharm Res 25:55-71
91. Sankaranarayanan J, Mahmoud EA, Kim G, Morachis JM, and Almutairi A (2010) Multiresponse strategies to modulate burst degradation and release from nanoparticles. ACS Nano 4:5930-5936
92. Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, Marceddu S, Bandiera P, Uzzau S, and Sechi M (2011) Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 54:1321-1332
93. Sarko D, Beijer B, Garcia Boy R, Nothelfer EM, Leotta K, Eisenhut M, Altmann A, Haberkorn U, and Mier W (2010) The pharmacokinetics of cell-penetrating peptides. Mol Pharm 7:2224-2231
94. Sethuraman VA and Bae YH (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 118:216-224
95. Seymour LW, Ferry DR, Anderson D, Hesslewood S, Julyan PJ, Poyner R, Doran J, Young AM, Burtles S, Kerr DJ, et al. (2002) Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J Clin Oncol 20:1668-1676
96. Shan X, Liu C, Yuan Y, Xu F, Tao X, Sheng Y, and Zhou H (2009) In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf B Biointerfaces 72:303-311
97. Shen Y, Tang H, Radosz M, Van Kirk E, and Murdoch WJ (2008) pH-responsive nanoparticles for cancer drug delivery. Methods Mol Biol 437:183-216
98. Shim MS and Kwon YJ (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J 277:4814-4827
99. Stephan MT, Moon JJ, Um SH, Bershteyn A, and Irvine DJ (2010) Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 16:1035-1041
100. Storm G, Belliot SO, Daemen T, and Lasic DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17:31-48
101. Suzuki A and Tanaka T (1990) Phase transition in polymer gels induced by visible light (Letter). Nature 346:345-347
102. Tabata Y, Inoue Y, and Ikada Y (1996) Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 14:1677-1685
103. Torchilin VP (2008) Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90:604-610
104. Turpeenniemi-Hujanen T (2005) Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 87:287-297.
105. van Duijnhoven SM, Robillard MS, Nicolay K, and Grüll H (2011) Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumorindependent activation. J Nucl Med 52:279-286.
106. van Etten EW, ten Kate MT, Stearne LE, and Bakker-Woudenberg IA (1995) Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Antimicrob Agents Chemother 39:1954-1958
107. Vila A, Sánchez A, Evora C, Soriano I, Vila Jato JL, and Alonso MJ (2004) PEG-PLA nanoparticles as carriers for nasal vaccine delivery. J Aerosol Med 17:174-185
108. Wang Z, Chui WK, and Ho PC (2011) Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy. Pharm Res 28:585-596
109. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, and Rothbard JB (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97: 13003-13008
110. Wendorf J, Chesko J, Kazzaz J, Ugozzoli M, Vajdy M, O'Hagan D, and Singh M (2008) A comparison of anionic nanoparticles and microparticles as vaccine delivery systems. Hum Vaccin 4:44-49
111. Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, and Tsien RY (2010) Parallel in vivo and in vitro selection using phage display identifies protease- dependent tumor-targeting peptides. J Biol Chem 285:22532-22541
112. Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, and Murthy N (2010) Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 9:923-928
113. Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, and Fukumura D (2011) Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA 108:2426-2431
114. Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, and Ning J (2008) Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Deliv Rev 60:939-954
115. You JO and Auguste DT (2009) Nanocarrier cross-linking density and pH sensitivity regulate intracellular gene transfer. Nano Lett 9:4467-4473
116. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, and Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761-769
117. Zhao C, He P, Xiao C, Gao X, Zhuang X, and Chen X (2011) Synthesis of temperature and pH-responsive crosslinked micelles from polypeptide-based graft copolymer. J Colloid Interface Sci 359:436-442
118. Zhou Y, Jiang K, Song Q, and Liu S (2007) Thermo-induced formation of unimolecular and multimolecular micelles from novel double hydrophilic multiblock copolymers of N,N-dimethylacrylamide and N-isopropylacrylamide. Langmuir 23: 13076-13084
119. Ziegler A, Nervi P, Dürrenberger M, and Seelig J (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44: 138-148.